Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
When facing a sarcoma diagnosis, clear Treatment Details are essential for making informed decisions about care. Liv Hospital’s dedicated sarcoma team provides a full spectrum of services, from precise imaging to cutting‑edge surgery, ensuring that each patient receives a personalized therapeutic plan. In 2022, sarcomas accounted for approximately 1% of adult cancers worldwide, highlighting the importance of specialized expertise. This page outlines the comprehensive approach used at our JCI‑accredited facility, covering diagnostic pathways, multidisciplinary planning, surgical techniques, radiation options, systemic therapies, and post‑treatment support. International patients can rely on our 360‑degree assistance, including interpreter services, travel coordination, and comfortable accommodation.
Our goal is to demystify the complex landscape of sarcoma care, presenting the essential Treatment Details you need to understand each step of your journey. Whether you are newly diagnosed or seeking a second opinion, the information below will help you navigate the options available at Liv Hospital.
Sarcomas arise from mesenchymal cells, giving rise to a diverse group of tumors that can develop in bone, muscle, fat, or connective tissue. The two main categories are soft‑tissue sarcoma and bone sarcoma, each with distinct subtypes such as liposarcoma, leiomyosarcoma, osteosarcoma, and Ewing’s sarcoma. Accurate diagnosis begins with a thorough clinical evaluation, followed by advanced imaging and tissue sampling.
Pathology reports include tumor grade, size, and molecular markers, which are critical for risk stratification. Liv Hospital’s pathology department utilizes immunohistochemistry and next‑generation sequencing to identify actionable mutations, informing targeted therapy decisions.
Effective sarcoma management relies on a coordinated team of specialists. At Liv Hospital, a multidisciplinary tumor board convenes weekly to review each case, integrating expertise from surgical oncology, medical oncology, radiation oncology, radiology, pathology, and rehabilitation services. This collaborative model ensures that Treatment Details are tailored to the individual’s tumor biology, location, and personal circumstances.
Discipline | Role in Treatment |
|---|---|
Surgical Oncology | Evaluates resectability and plans operative approach. |
Medical Oncology | Recommends chemotherapy, targeted agents, or immunotherapy. |
Radiation Oncology | Designs radiation fields and selects appropriate modalities. |
Radiology | Provides imaging for staging and treatment monitoring. |
Pathology | Delivers definitive diagnosis and molecular profiling. |
Rehabilitation | Creates postoperative recovery and functional restoration plans. |
Patients receive a written summary of the proposed plan, including timelines, expected outcomes, and potential side effects. This transparency empowers patients to actively participate in their care.
Surgery remains the cornerstone of curative intent for most localized sarcomas. The primary objective is to achieve wide negative margins while preserving function. Liv Hospital employs both conventional and minimally invasive techniques, guided by intra‑operative imaging and, when appropriate, robotic assistance.
Advanced technologies such as intra‑operative navigation and fluorescence-guided surgery enhance precision, reducing the risk of residual disease. For bone sarcomas, endoprosthetic reconstruction or allograft implantation may be performed to restore structural integrity.
Radiation therapy complements surgery, especially when achieving wide margins is challenging. Liv Hospital offers a suite of modern radiation techniques designed to maximize tumor control while sparing surrounding healthy tissue.
Pre‑operative (neoadjuvant) radiation can shrink tumors, facilitating less extensive surgery. Post‑operative (adjuvant) radiation reduces the risk of local recurrence when margins are close or positive. Treatment plans are individualized based on tumor size, location, and prior therapies.
Systemic treatment addresses microscopic disease and metastatic sarcoma. The choice of regimen depends on histologic subtype, genetic alterations, and patient tolerance. Liv Hospital’s oncology team stays current with emerging clinical trials, offering access to novel agents.
Below is a comparative overview of commonly used systemic agents for sarcoma:
Agent | Mechanism | Typical Indication | Key Side Effects |
|---|---|---|---|
Doxorubicin | DNA intercalation, topoisomerase II inhibition | First‑line for most soft‑tissue sarcomas | Cardiotoxicity, alopecia, myelosuppression |
Ifosfamide | Alkylating agent causing DNA cross‑linking | Often combined with doxorubicin | Nephrotoxicity, neurotoxicity, hemorrhagic cystitis |
Pazopanib | VEGF receptor tyrosine‑kinase inhibition | Advanced non‑liposomal soft‑tissue sarcoma | Hypertension, liver enzyme elevation, diarrhea |
Pembrolizumab | PD‑1 checkpoint inhibition | Selected metastatic sarcomas in clinical trials | Immune‑related adverse events (colitis, dermatitis) |
Patients receive thorough counseling on expected benefits, potential toxicities, and supportive care measures such as growth‑factor support, anti‑emetics, and cardiac monitoring.
Recovery after sarcoma therapy extends beyond the hospital stay. Liv Hospital provides a comprehensive survivorship program that addresses physical, emotional, and functional needs.
Regular follow‑up visits are scheduled based on risk stratification, typically every 3–6 months for the first two years, then annually. The care team monitors for late effects of radiation, chemotherapy‑induced organ toxicity, and functional outcomes, adjusting the rehabilitation plan as needed.
Liv Hospital combines JCI‑accredited standards with a global patient‑focused approach. Our sarcoma specialists have extensive experience treating complex cases from around the world. International patients benefit from seamless coordination of appointments, visa assistance, interpreter services, and comfortable accommodation options, ensuring that medical care remains the primary focus.
Ready to discuss your sarcoma treatment plan with our expert team? Contact Liv Hospital today to schedule a virtual consultation and take the first step toward personalized, world‑class care.
Send us all your questions or requests, and our expert team will assist you.
Sarcomas arise from mesenchymal cells and can develop in bone, muscle, fat, or connective tissue. The two primary categories are soft‑tissue sarcoma and bone sarcoma, each containing many subtypes such as liposarcoma, leiomyosarcoma, osteosarcoma, and Ewing’s sarcoma. Diagnosis starts with a clinical exam followed by advanced imaging—MRI for soft tissue, CT for bone involvement, and PET for metabolic activity. A core needle or open biopsy performed by a sarcoma‑experienced pathologist provides tissue for histology, grading, and molecular profiling, which guides treatment decisions.
Liv Hospital convenes a multidisciplinary tumor board every week. Specialists from surgical oncology, medical oncology, radiation oncology, radiology, pathology, and rehabilitation discuss each patient’s imaging, pathology, molecular data, and personal circumstances. The team decides on resectability, the need for neoadjuvant or adjuvant therapies, and rehabilitation goals. A written summary outlining timelines, expected outcomes, and side‑effects is provided to the patient, ensuring transparency and shared decision‑making.
Surgery remains the cornerstone for localized sarcomas. Wide excision removes the tumor with a cuff of healthy tissue to achieve clear margins. Compartmental resection takes the entire anatomical compartment containing the tumor, used for high‑grade lesions. Limb‑sparing surgery combines tumor removal with reconstructive techniques to preserve function, while amputation is reserved for cases where limb preservation would compromise oncologic safety. Liv Hospital employs intra‑operative navigation, fluorescence guidance, and robotic assistance to enhance precision, and for bone sarcomas may use endoprosthetic reconstruction or allografts.
Radiation therapy complements surgery, especially when wide margins are difficult. Liv Hospital offers conventional external beam radiation therapy (EBRT) delivered in fractions, intensity‑modulated radiation therapy (IMRT) for dose sculpting around critical structures, proton beam therapy which provides superior dose distribution for deep‑seated or pediatric sarcomas, and intra‑operative radiation therapy (IORT) that delivers a single high dose directly to the tumor bed during surgery. Neoadjuvant radiation can shrink tumors to enable less extensive surgery, while adjuvant radiation reduces local recurrence risk when margins are close.
Liv Hospital’s international patient program offers a 360‑degree support system. Dedicated coordinators help with visa applications, arrange airport transfers, and schedule appointments to minimize wait times. Professional interpreters are available for over 30 languages, ensuring clear communication during consultations and treatment. The hospital partners with nearby hotels and provides on‑site accommodation options, allowing patients and families to focus on care rather than logistics. All services are coordinated by a single point of contact.
Cancer
Cancer
Cancer
Cancer
Cancer
CancerYour Comparison List (you must select at least 2 packages)